| Literature DB >> 20625539 |
Timo Weide1, S Adrian Saldanha, Dmitriy Minond, Timothy P Spicer, Joseph R Fotsing, Michael Spaargaren, Jean-Marie Frère, Carine Bebrone, K Barry Sharpless, Peter S Hodder, Valery V Fokin.
Abstract
Metallo-ß-lactamases (MBL) are an emerging cause of bacterial resistance to antibiotic treatment. The VIM-2 ß-lactamase is the most commonly encountered MBL in clinical isolates worldwide. Described here are potent and selective small molecule inhibitors of VIM-2 containing the arylsulfonyl-NH-1,2,3-triazole chemotype that potentiate the efficacy of the ß-lactam, imipenem, in E. coli.Entities:
Year: 2010 PMID: 20625539 PMCID: PMC2901175 DOI: 10.1021/ml900022q
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345